Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1020 results for "ranbaxy industries"

Sell or hold shares in M&A deals?
Livemint.com

Sun Pharmaceutical Industries Ltd to acquire Ranbaxy Laborator...

Deals Sun Pharmaceutical Industries Ltd has agreed to acquire Ranbaxy Laboratories Ltd for a total consideration of $3.99 billion. Value: $4.0 billion Announced: April 07 2014 Parties involved Legal advisers Sun ... International Law Office, 1 week ago
Sell or hold shares in M&A deals? Livemint.com, 1 week ago
[x]  

70 images for ranbaxy industries

The Hindu, 2 weeks ago
The Hindu, 2 weeks ago
Irish Times, 2 weeks ago
Rediff.com, 2 weeks ago
Rediff.com, 1 week ago
Rediff.com, 1 week ago
Sify, 1 week ago
Rediff.com, 1 week ago
Rediff.com, 1 week ago
Rediff.com, 2 weeks ago
Business Today India

SEBI queries Sun on Ranbaxy deal

The market regulator, Securities and Exchange Board of India (SEBI), has sought information from Sun Pharmaceutical Industries on the Ranbaxy deal. Comments have been sought on stock price movement and the deal structure, sources told Business ...
 Hindu Business Line1 week ago Sebi smells rat in Sun Pharma-Ranbaxy deal  Business Today India1 week ago Ranbaxy Laboratories : Sebi smells rat in deal  4 Traders2 weeks ago Brokers' association to ask Sebi to investigate Ranbaxy trades  Business Standard India2 weeks ago
[x]  
Finance 24

Investors bet Sun Pharma can heal rival Ranbaxy

On the surface, Sun Pharmaceutical Industries Ltd's US$3.2 billion purchase of Indian generics rival Ranbaxy Laboratories Ltd, which is in deep trouble with US regulators over safety lapses, may not look like a great deal. Yet Sun Pharm's shares ...
 Taipei Times Online1 week ago Investors back Sun Pharma's Ranbaxy move (AFP)  West Australian1 week ago Investors back Sun's Ranbaxy deal as well-calculated risky acquisition  Oman Tribune1 week ago Sun Pharma is able to revive Ranbaxy: investors  China Post1 week ago
[x]  
Financial Express

Sun Pharmaceuticals chief Israel Makov hopes the worst is over for Ranbaxy Laboratories

Sun Pharmaceuticals Industries would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy Laboratories Ltd facilities but it has not put any time-frame for this, company Chairman Israel Makov said today. Sun Pharma's experience ...
 Financial Express2 weeks ago Sun Pharma chief hopes the worst is over for Ranbaxy  Times of India2 weeks ago Sun chief hopes the worst is over for Ranbaxy  Rediff.com2 weeks ago Sun Pharma chief Israel Makov hopes the worst is over for Ranbaxy  Times of India2 weeks ago
[x]  
Money Control

Stocks in news: Sun Pharma, Ranbaxy, SBI, BHEL, Escorts

Sun Pharma | Ranbaxy Labs | Escorts | SBI | Gammon Infrastructure | Mercator | SAIL | Man Industries | Cairn India | Reliance Industries | Tata Steel and BHEL are stocks, which are in the news today.
 Money Control2 weeks ago Stocks in news: Man Ind, Tata Tele, SBI, Torrent Pharma  Money Control2 weeks ago Top 10 stocks: Keey an eye on Sun,Ranbaxy,Cipla,HDIL  Money Control2 weeks ago Here are stocks to focus on March 11  Money Control1 month ago
Livemint.com

Sun Pharmaceutical Industries Ltd, Ranbaxy Laboratories Merger Equals Generic Powerhouse: Layoffs Projected To Save $250 Million In Costs

Sun Pharma is axing jobs but others are hiring too! Check it out! (Isn't it tempting?) The merger of Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd will create the world's fifth biggest generic drug maker, but it will also result in ...
 BioSpace1 week ago Sun Pharma, Ranbaxy merger: Layoffs, supply synergy key to $250 mn savings  Livemint.com1 week ago See $250 mn in operating synergies from Ranbaxy deal: Sun  Moneycontrol.com2 weeks ago

Sun Pharma (Buy)

Sun Pharmaceutical Industries has entered into a definitive agreement with Ranbaxy to acquire the company through purchase of all outstanding shares at 457 a share. The price per share is worked upon the deal being a swap of shares of 0.8 shares of Sun Pharma ...
 Business Line2 weeks ago Sun Pharma to takeover Ranbaxy for US$ 4 billion  PharmaBiz2 weeks ago Sun Pharma To Acquire Ranbaxy  Contract Pharma2 weeks ago Sun Pharmaceutical to acquire 100% stake in Ranbaxy Laboratories  PredictWallStreet2 weeks ago
Business Standard India

`premature to talk of changes in ranbaxy management team now'

04/15/2014 | 07:29am US/Eastern Recommend: Israel Makov , the chairman of Sun Pharmaceutical Industries Limited (Sun), has stated that it is too premature to consider making any changes in the management of Ranbaxy Laboratories ...
 4 Traders1 week ago Premature to talk of changes in Ranbaxy management team now  Business Standard India1 week ago 'Premature to talk of changes in Ranbaxy top brass now'  Rediff.com1 week ago
Business Standard India

Ranbaxy may have to pay huge fine, again

Ranbaxy Laboratories, set to be merged with Sun Pharmaceutical Industries, might again have to pay a hefty penalty to the US authorities for alleged violations at its Toansa factory in Punjab. The facility is currently banned from supplying products ...
 Business Standard India1 week ago
[x]  

Accumulate Sun Pharma; target of Rs 646: P Lilladher

Prabhudas Lilladher's report on Sun Pharmaceutical Industries "Sun Pharma acquired Ranbaxy at an all-stock deal of USD 4bn, including equity value of USD 3.2bn and debt of USD 800m. Per deal, Ranbaxy to merge with Sun Pharma at a stock swap ratio ...
 Moneycontrol.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less